Skip to content

Boosted and unboosted atazanavir maintain viral suppression equally well

Boosted darunavir monotherapy works well in two studies

Aciclovir reduces disease progression and death in people with HIV by nearly 20 per cent

Early tests of maraviroc as microbicide produce less activity than expected

Anal cancer in men with HIV much more common in post-HAART era: could HPV vaccination help?

Sustained response to interferon improves fibrosis in HIV/HCV co-infected patients

Delays in starting treatment common in ART programmes

Antiretroviral roll-out results in major TB decline in South African study

Improved surveillance of cervical cancer recommended in populations with high HIV prevalence